Top 50 Medical Device Startup Investors in Spain (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
11 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $170k–$15M |
|
Criteria Venture Tech
VC Fund
|
8 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
Asabys Partners
VC Fund
|
7 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.3M–$135M |
|
BeAble Capital
VC Fund
|
6 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
ENISA
VC Fund
|
6 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$1.6M |
|
Clave Capital
VC Fund
|
6 | Spain, Chile, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Software | $462k–$21M |
|
Bullnet Capital
VC Fund
|
5 | Spain, United States, Mexico | Seed, Series A | Software, Manufacturing, Information Technology | $567k–$11M |
|
BStartup - Banc Sabadell
VC Fund
|
5 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.3M |
|
ICF Capital
VC Fund
|
4 | Spain, United States, Mexico | Debt Financing, Seed | Software, Health Care, Artificial Intelligence | $110k–$6.9M |
|
CRB Inverbío
VC Fund
|
4 | Spain, Italy, Mexico | Series A, Seed | Health Care, Medical, Biotechnology | $2.2M–$8.9M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
3 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $266k–$16M |
|
Wellington Partners
VC Fund
|
3 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $3.1M–$60M |
|
Innogest Capital
VC Fund
|
3 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
Grow Venture Partners
VC Fund
|
3 | Spain, Sweden | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Biotechnology | $106k–$9.5M |
|
EASO Ventures
VC Fund
|
3 | Spain, Switzerland | Seed, Venture - Series Unknown | Software, Health Care, Manufacturing | $229k–$4M |
|
WA4STEAM
VC Fund
|
3 | Spain | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Biotechnology, Artificial Intelligence | $392k–$11M |
|
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund
|
3 | Spain | Series A, Grant, Pre-Seed | Semiconductor, Life Science, Manufacturing | $390k–$1.4M |
|
Clave Mayor
VC Fund
|
3 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
Banc Sabadell and the Institut Català de Finances (ICF)
VC Fund
|
2 | Spain, Switzerland | Debt Financing, Seed, Pre-Seed | Wellness, Health Care, Medical Device | $186k–$425M |
|
Shilling VC
VC Fund
|
2 | Portugal, Spain, United States | Seed, Pre-Seed, Series A | Information Technology, Software, Artificial Intelligence | $125k–$20M |
|
Caixa Capital
VC Fund
|
2 | Portugal, United States, Spain | Seed, Series A, Series B | Software, Information Technology, Health Care | $120k–$23M |
|
Ysios Capital
VC Fund
|
2 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
CG Health Ventures
VC Fund
|
2 | United States, Spain | Series A, Seed, Convertible Note | Health Care, Medical, Women's | $549k–$37M |
|
Inveready
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Health Care | |
|
CDTI
VC Fund
|
2 | Spain, United States, Mexico | Venture - Series Unknown, Seed | Software, Information Technology, Health Care | $314k–$5.4M |
|
Banco Sabadell
VC Fund
|
2 | Spain, United Kingdom, Mexico | Seed, Debt Financing, Series A | Software, E-Commerce, Internet | $252k–$1000M |
|
Juan Knuth
Angel
|
2 | Spain | Seed, Series A | Health Care, Biotechnology, Digital Media | |
|
Alta Life Sciences
VC Fund
|
2 | Spain, United States | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Therapeutics | $3M–$87M |
|
Murcia Emprende
VC Fund
|
2 | Spain | Seed | Biometrics, Health Care, Medical Device | $1.1M–$2.1M |
|
MTIP AG
VC Fund
|
2 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Medical, Artificial Intelligence | $1.5M–$80M |
|
Ancora Finance Group
VC Fund
|
2 | Spain, Germany | Series A | Medical, Medical Device, Health Care | $2.6M–$36M |
|
ENDRA
VC Fund
|
2 | Spain | Series A, Series D | Information Technology, Software, Training | |
|
Orza Investments
VC Fund
|
2 | Spain | Venture - Series Unknown, Seed | Medical, Biotechnology, Medical Device | $1.1M–$19M |
|
Unconventional Ventures
VC Fund
|
2 | Sweden, Denmark, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Software, Wellness | $1M–$18M |
|
AA Sons
VC Fund
|
2 | France, United States, Israel | Seed, Series A, Series B | Software, E-Commerce, FinTech | $1.1M–$74M |
|
Nara Capital
VC Fund
|
2 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
Capital Cell
VC Fund
|
2 | Spain, France, United States | Equity Crowdfunding, Seed, Series A | Health Care, Biotechnology, Medical | $137k–$21M |
|
GENESIS Ventures
VC Fund
|
2 | Spain | Seed | Health Care, Medical Device, Medical | $772k–$1.4M |
|
SODENA
VC Fund
|
2 | Spain, United Kingdom | Debt Financing, Seed | Health Care, Biotechnology, Manufacturing | $37k–$1.2M |
|
Morningside
VC Fund
|
1 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | |
|
Dozen Investments
VC Fund
|
1 | Spain, United Kingdom | Seed, Series A | Software, Mobile Apps, SaaS | |
|
Gestion De Capital Riesgo Del Pais Vasco
VC Fund
|
1 | Spain | Seed, Series A | Biotechnology, Health Care, Medical | |
|
Genesis Ventures
VC Fund
|
1 | Chile, China, Japan | Seed, Pre-Seed, Series A | Software, FinTech, Financial Services | $137k–$6M |
|
Sabadell Venture Capital
VC Fund
|
1 | Spain, Mexico, United Kingdom | Seed, Series A | Software, FinTech, Internet | $1M–$6.8M |
|
EIT Health
VC Fund
|
1 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $22k–$1.6M |
|
European Commission
VC Fund
|
1 | France, Spain, Germany | Grant, Seed, Pre-Seed | Software, Biotechnology, Health Care | $55k–$88M |
|
APX
VC Fund
|
1 | Germany, United Kingdom, United States | Pre-Seed, Seed, Series A | Software, SaaS, Information Technology | $55k–$15M |
|
Gerald Heydenreich
Angel
|
1 | Spain, Germany | Seed, Pre-Seed | Retail, Content, Women's | $88k–$768k |
|
Kurma Partners
VC Fund
|
1 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
VI Partners
VC Fund
|
1 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
| Access all 189 investors in Spain Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 217
- Round size: Seed $576k–$5.8M; Grant $170k–$15M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Phoenix Foods — Phoenix Foods uses insect farming to solve the problems of organic waste management and the requirement for high-quality proteins in animal feed.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 158
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Fostering breakthrough innovation in healthcareAsabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. PORTFOLIO TEAM Impact We want to push the boundaries of science and medicine improving patient's life Disruptive We look for highly innovative and transformative technologies Hands-on We consider ourselves partners and collaborators to our portfolio
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.3M–$13M; Series A $7M–$57M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 69
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$274k
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Molecular Gate — Transformative Anti-Counterfeiting Technology. Multifunctional Level 1 Anti-Counterfeit Solutions: See-through Polargram and Reflective Polargram
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 231
- Round size: Seed $67k–$1.6M; Pre-Seed $165k–$1.2M; Debt Financing $66k–$489k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Biotasmart — Plataforma que convierte datos de la microbiota intestinal en recomendaciones nutricionales personalizadas.
- DARWIN Biomed — Biomedical Engineering
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 45
- Round size: Seed $462k–$5.5M; Series A $3.2M–$21M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 66
- Round size: Seed $1M–$3.2M; Series A $567k–$11M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — Impetux is a worldwide key manufacturer and supplier of turnkey optical tweezers systems designed for mechanobiology studies in living cells and 3D tissues.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 84
- Round size: Seed $110k–$2.3M; Pre-Seed $219k–$900k
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 115
- Round size: Seed $1.2M–$6.9M; Debt Financing $110k–$1.7M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Kintai — Kintai's a lending platform aiming to help small and medium companies with their funding needs. Based on a merchant cash advance model, companies can return their loans on a daily basis with low frictionless amounts.
- Covides — Covides is a prominent Spanish wine cooperative that integrates grape production, vinification, and international commercial distribution for local winegrowers.
- ATTSU — ATTSU is leader manufacturer of industrial steam boilers, thermal oil boilers and superheated water boilers. Available on a wide variety of fuels.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Italy, Mexico
Investor stats
- Total investments: 16
- Round size: Seed $3.3M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $70M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 52
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Zoundream — The Future of Infant Care
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 201
- Round size: Series A $3.1M–$36M; Series B $8.3M–$60M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $222M in 2019
Portfolio highlights
- nyra health — nyra health is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. nyra health was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Founded to serve patients through transformative medicines
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- X1 Wind — X1 Wind is a disruptive innovative floating wind platform with the potential to make a step change in offshore wind.
- NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 77
- Round size: Seed $266k–$3.2M; Venture - Series Unknown $229k–$4M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- DARWIN Biomed — Biomedical Engineering
WA4STEAM is an all women angels investment group delivering worldwide access to seed capital for women entrepreneurs led startups in STEAM Science, Technology, Engineering , Architecture & Architecture and Mathematics
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 22
- Round size: Seed $392k–$4.2M; Pre-Seed $671k–$1.2M; Venture - Series Unknown $6.1M–$11M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Hair Up Laser — Making alopecia a problem of the past.
- Genbioma — Genbioma is a biotechnology company transforming microbiome science into clinically validated postbiotics that support metabolic health, improve glucose control, and naturally activate the GLP-1 pathway.
- Onalabs Inno-hub — Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower thepatients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes.
CDTI
Show more...Investment focus
- Industry: Semiconductor, Life Science, Manufacturing
- Stage:Series A, Grant, Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 11
- Round size: Series A $390k–$1.4M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Basquevolt — Basquevolt is a leader in solid state battery technology.
- FYLA — FYLA designs ultrafast fiber lasers, combining precision engineering and quality. Discover supercontinuum and femtosecond laser solutions.
- A4CELL — A4CELL is a company that develops SPAchip (suspended planar-array chips) that help monitor living single cells. They offer SPAchips, as well as the CytoCHECK SPAchip and the CytoCHECK SPAchip. The company's goal is to increase the accuracy and quality of cell study data in order to better understand disease behavior.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Banc Sabadell and the Institut Català de Finances (ICF)
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Debt Financing, Seed, Pre-Seed
- Geography: Spain, Switzerland
Investor stats
- Total investments: 6
- Round size: Debt Financing $186k–$425M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
- NH Hoteles — NH Hotel Group is a consolidated travel and leisure hotel operator. It is one of the top 25 hotel chains in the world and one of the main ones in Europe, currently operating close to 400 hotels with almost 60,000 rooms in 31 countries in Europe, America, and Africa.
- Impala Terminals — Impala Terminals Group facilitates the global trade of commodities by offering producers and consumers reliable and efficient access to international markets.
Shilling is an early-stage venture capital firm backing exceptional founders from the start.Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, directaccess to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 107
- Round size: Seed $603k–$5M; Pre-Seed $125k–$3M; Series A $5M–$20M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Tucuvi — Tucuvi is a health technology company unlocking efficient and high-quality healthcare at scale with a CE-marked platform for Phone Consultation Automation. We develop safe and clinically validated Conversational AI for any care pathway, enabling clinical teams to augment their capacities, improve processes’ efficiency and efficacy, and achievebetter patient outcomes and satisfaction through continuous and personalized care.
- Balance — Balance is a private digital health company based in Spain that operates in the clinics and outpatient healthcare services sector. company's core mission is to provide an integrated, medical, and sustainable approach to treating obesity and overweight conditions. Moving away from traditional restrictive diets, the company leverages asubscription-based telehealth model combined with clinical pharmacology.
- Punto Health — AI-powered digital platform for management of Alzheimer's and other dementias.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 78
- Round size: Seed $120k–$3M; Series A $3M–$12M; Series B $1.1M–$23M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Veniam — Transfer 10x more data for your video telematics, fleet operations, industrial IoT or connected vehicles.
- Growappy — Growappy is an EdTech that offers an all-in-one platform for early education that is leading a vision to unlock personalized education since nursery with the power of AI, while providing a revolutionary communication experience between schools and families and drastically simplifying bureaucracy for teachers and school owners.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 81
- Round size: Series A $3.8M–$62M; Series B $20M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
CG Health Ventures is a venture capital firm that seeks to invest in the health IT, digital health and genomics domain.
Show more...Investment focus
- Industry: Health Care, Medical, Women's
- Stage:Series A, Seed, Convertible Note
- Geography: United States, Spain
Investor stats
- Total investments: 6
- Round size: Seed $549k–$6M; Series A $7.7M–$37M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Babyscripts — Babyscripts is the turnkey virtual maternity care solution, increasing access to healthcare and improving maternal health outcomes.
- Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
- Cercle — We transform healthcare data at scale into high-quality insights so our customers can run more efficiently and provide more personalized care
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 134
- Lead/follow: no public data
Portfolio highlights
- Orbidi — Orbidi is a digital marketing agency that provides SEO, website building, and Google Maps integration services for businesses.
- Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
- The Channel Store — The Channel Store is a company specializing in the creation, distribution, and monetization of various types of channels, particularly in the FAST (Free Ad-Supported Streaming TV) and AVOD (Ad-Supported Video on Demand) sectors. It operates as a B2B service provider that manages content negotiations, integration, and monetization for its partners,enabling broadcasters, content owners, telcos, and streaming services to access and distribute a wide range of live and on-demand content globally.
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 36
- Round size: Seed $314k–$2.6M; Venture - Series Unknown $765k–$5.4M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Banco Sabadell is a banking group that specializes in serving small and medium enterprises. It comprises of several banks, brands, subsidiaries, and associated banks. The company was founded in 1881 and is headquartered in Alicante, Spain.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Debt Financing, Series A
- Geography: Spain, United Kingdom, Mexico
Investor stats
- Total investments: 78
- Round size: Seed $252k–$6.5M; Series A $1M–$20M; Debt Financing $3M–$1000M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Sonnedix — Sonnedix is an Independent Solar Power Producer (IPP) with a proven track record in delivering high performance cost competitive solar photovoltaic plants to the market.
- NeuralTrust — NeuralTrust is the leading security platform for generative AI, offering a unified command center for real-time defense and offense. Its open source AI gateway delivers the fastest performance in the market for managing LLM traffic, while its automated red teaming engine proactively uncovers vulnerabilities, ensuring robust protection for your AIsystems.
- Catalonia Hotels & Resorts — Catalonia Hotels & Resorts is a hotel chain that offers loyalty program to take care of the customer's stay.
Juan Knuth
Show more...Investment focus
- Industry: Health Care, Biotechnology, Digital Media
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Devicare — Devicare is a specialty biotech company dedicated to developing groundbreaking medical treatments in Urology by combining innovative therapies with digital technologies.Devicare is dedicated to improving and easing the lives of patients who suffer from urological diseases and disorders. Devicare's vision is to be a ground-breaking leader inurology with innovative medical treatments, patent protected, clinically-proven and patient-centric.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$33M; Series B $13M–$87M; Venture - Series Unknown $3.3M–$13M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Financing initiatives of entrepreneurs and growing companies.
Show more...Investment focus
- Industry: Biometrics, Health Care, Medical Device
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 4
- Round size: Seed $1.1M–$2.1M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Inbentus — Inbentus provides mechanical ventilation and other medical devices. They provide support and consulting services for the development of medical products. They provide information on mechanical ventilation systems. They develop the respirator with the support of the RIS3MUR program. They also provides technical support services.
- Biometric Vox — Biometric Vox is development of applications for fast and secure identification by voice.
- Viva In Vitro — Viva In Vitro is a health care company.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 28
- Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ancora Finance Group is an international management consulting firm that offers unparalleled leadership, strategic, and operational advice. Their focus on financial services is deeply rooted in the DNA of their company as it comes from their people. They are based in London and Singapore, providing unparalleled leadership, strategic andoperational solutions for the financial services industry. Their experience, expertise, and approach combine consulting and knowledge transfer.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Series A
- Geography: Spain, Germany
Investor stats
- Total investments: 3
- Round size: Series A $2.6M–$36M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Koa Health — Make mental health manageable, treatable, and approachable for every industry and every individual with clinical-first care designed by experts. From evidence-based self-care and prevention through clinical treatment and therapy, Koa Health supports workforce wellbeing across the continuum.
- Atlas Medical Technologies — Atlas Medical Technologies is a manufacturing company that develops navigation systems for medical doctors for radiology and orthopedics.
ENDRA is an investment firm.
Show more...Investment focus
- Industry: Information Technology, Software, Training
- Stage:Series A, Series D
- Geography: Spain
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
- SquarePoint — SquarePoint provides HR solutions, functional consulting, project management, in-company training, maintenance, and software services.
- Worldsensing — Welcome to the home of IoT wireless monitoring for critical infrastructures. Find out how we use technology to improve your safety every day.
ORZA is a direct investment entity, part of the ELKARKIDETZA and GEROA pension funds, which deals with the acquisition of shares in businesses.It supports the Basque business sector through expansion and internationalisation projects, MBO and MBI transactions, to resolve questions of corporate succession and in the substitution of minorityshareholders.
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Seed
- Geography: Spain
Investor stats
- Total investments: 8
- Round size: Seed $1.1M–$5M; Venture - Series Unknown $1.2M–$19M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- SATLANTIS — Scientific space technology for Earth observation and space monitoring, delivering reliable observational data.
- Mikrobiomik — Mikrobiomik is a biopharmaceutical company that provides innovative solutions for chronic diseases.
- Deneb Medical — Deneb Medical is a start-up dedicated to developing a robotic platform for applications in neurosurgery, CMF surgery, head and neck surgery, urology and general surgery.
Unconventional Ventures invests in startups in the pre-seed and seed stage led by diverse founders identifying as women, people of color, immigrants and/or LGBTQ+, building scalable impact tech companies in the Nordics and beyond.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 19
- Round size: Seed $1M–$5.2M; Pre-Seed $1.5M–$2.8M; Series A $4.7M–$18M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- AIRMO — AIRMO is supporting the direct emitters, decision makers and financial institutions to efficiently transition to Net-0 by monitoring their direct emissions from space. With our roots in innovation and a commitment to environmental responsibility, we aim to revolutionize GHG monitoring through advanced satellite technology, proprietary LiDARinstrument and data analytics. We exist to monitor and manage humanity's impact on Earth.
- Digiclean Solutions — AI-powered process chemical control that gives you lower costs, higher efficiency, and a radically smaller footprint.
Bengkulutoto hadir sebagai solusi ideal bagi para pencinta angka jitu. Dengan predikat sebagai bandar togel online terlengkap, situs ini menawarkan keunggulan berupa proses deposit super cepat, serta sistem bermain yang adil dan transparan.
Show more...Investment focus
- Industry: Software, E-Commerce, FinTech
- Stage:Seed, Series A, Series B
- Geography: France, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $1.1M–$9M; Series A $5.8M–$36M; Series B $18M–$74M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- HUG — Join our global creative community to showcase & sell your art, connect with others, and access creator-friendly grants and education.
- Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
- Multiwave Technologies — More than 2/3 of humanity has no access to medical imaging Our mission is to make MRI available globally, through our ultra-low field mobile device.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed, Series A
- Geography: Spain, France, United States
Investor stats
- Total investments: 52
- Round size: Seed $384k–$1.9M; Series A $1.1M–$21M; Equity Crowdfunding $137k–$1.5M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
GENESIS Ventures is an investment vehicle located in Barcelona and built up in partnership with family offices. The new fund is sized in 610.000 € and will invest in recently created Start-ups or entrepreneurial projects with a clear aim to develop innovative products through the creation of a Start-up company in the biomedical and biotechnologicalfield (therapeutics, diagnostics, medical devices and others). The investment platform is envisaged as a very early-stage tool to help the development of excellent scientific projects to reach key value milestones to attract a first round of investment from venture or corporate funds.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Seed $772k–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Corify Care — CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to introduce in the market a novel medical device to non-invasively map cardiac arrhythmias in real time. This novel technology will improve the treatment in more than 10 million of atrial fibrillation patients only in Europe. Our non-invasiveelectro-anatomical mapping systems displays the activation patterns in each point of the heart without the need of invasive catheters, allowing the possibility to map all atrial fibrillation patients even during a regular visit to the cardiologist. CORIFY Care is located in Madrid, Spain, one of the most attractive places to work/live on the South of Europe.
- Renalyse — Renalyse is the registered trade name of CreatSens Health S.L., a biotechnology company focusing on the development of medical platforms.
- ABLE Human Motion — Next-generation exoskeleton technology to enable mobility for all.
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Debt Financing, Seed
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $110k–$1.2M; Debt Financing $37k–$743k
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Muxunav — Muxunav specialize in digital payment systems, they might be working on technologies like mobile payment solutions, online transaction systems, digital wallets, or even blockchain-based payment methods.
- El Caserío de Tafalla — El Caserío de Tafalla is a food production company that processes and supplies a variety of candies.
Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically.Based in the greater Boston area, our team of entrepreneurial investment professionals has deep experience in life sciences, digital health,AI, materials and technology.Founded in 1986 as a family office for the Chan family, charitable commitments to education, research and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 106
- Lead/follow: no public data
Portfolio highlights
- Xealth — Connect your digital health vendors so doctors can order, deliver and monitor care from a single digital health integration platform.
- AdvanCell — AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
- SimpliFed — SimpliFed provides virtual breastfeeding and baby feeding support fully covered by your health plan from pregnancy to weaning.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dozen Investments is a venture capital and private equity firm based in Spain.
Show more...Investment focus
- Industry: Software, Mobile Apps, SaaS
- Stage:Seed, Series A
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 24
- Lead/follow: no public data
Portfolio highlights
- CubicUp — CubicUp is the person of confidence that accompanies you in your project of Reform from Begin to Finish.
- Poseidona — Sustainable proteins from algal waste and invasive biomass
- Bloome — La forma moderna de cuidarte (por dentro y por fuera)
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Irisbond — Irisbond creates a new way for humans to communicate through precision eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Developed for use in mobile devices, automotive, smart homes, robotics, scientific,healthcare and manufacturing, eye tracking technology lets you learn, play, work and communicate with your eyes. A pioneer in the assistive technology market, Irisbond’s eye tracking solutions are based on years of R&D in cooperation with Vicomtech, a leader in the field of artificial vision. For more information about the power of the eyes, go to www.irisbond.com/en
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Inmedical Therapeutics — Inmedical Therapeutics is centered on the creation of the Covergel product, which is intended to avoid difficulties in therapeutic endoscopies
Genesis Ventures is a venture capital firm that seeks to invest in entrepreneurs with a global ambition. The firm provides multi-stage venture capital to proven and innovative technology enabled businesses, as well mentoring and support to internationalize their businesses.The firm believes in social and environmental responsible investment andseeks to adhere and enforce the Principles for Responsible Investment (PRI).Genesis Ventures headquartered in Santiago de Chile with local teams in Bogotá, Lima, London, Edinburgh, Miami, and Berlin.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: Chile, China, Japan
Investor stats
- Total investments: 16
- Round size: Seed $137k–$6M; Pre-Seed $200k–$4M; Series A $2.8M–$2.8M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- myTeam — Helping Sports Clubs and Academies to optimize their daily processes and communication with their members
- Finloup — Finloup is a buy now, pay later FinTech that increases consumer purchasing power and uses Open Banking to ensure responsible spending.
- Kredito — Kredito is a platform that focuses on generating loans for small to medium-sized businesses.
Sabadell Venture Capital's main purpose is to support entrepreneurial Spanish projects during their initial stages (Seed and Early Stage). They want to be the financial partner of the startups and to be part of its innovative and transformative projects. They add value to the company through the different stages of its growth. Banco Sabadellis defined by its entrepreneurial spirit: “A bank by entrepreneurs, for entrepreneurs, helping entrepreneurs".
Show more...Investment focus
- Industry: Software, FinTech, Internet
- Stage:Seed, Series A
- Geography: Spain, Mexico, United Kingdom
Investor stats
- Total investments: 82
- Round size: Seed $1M–$5.8M; Series A $2.9M–$6.8M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Cofers — Cofers es una plataforma Cloud de gestión y conciliación de la tesorería para empresas en Mexico.
- Zazume — Zazume is an end-to-end rental management software simplifying the entire letting process for real estate companies, landlords. It works with real estate professionals, from letting agencies to property managers (Built-to-Rent, coliving, opcos, family offices, REIT, student housing…) to replace manual with digital processes and optimize thetenant’s journey from search to living. Zazume is an end-to-end rental management software simplifying the entire letting process for real estate companies, landlords.
- Amelia Hub — Amelia is a a drone services company
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 97
- Round size: Seed $220k–$1.4M; Grant $22k–$1.6M; Pre-Seed $44k–$1.4M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Grant, Seed, Pre-Seed
- Geography: France, Spain, Germany
Investor stats
- Total investments: 261
- Round size: Seed $117k–$5.4M; Grant $127k–$88M; Pre-Seed $55k–$5.4M
- Lead/follow: 70% lead, 30% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Leonardo Company — Leader in Aerospace, Defence & Security
- Leonardo — Leonardo is a security company that develops multi-domain technology capabilities for AD&S.
- Egyptian Electricity Transmission Company — Egyptian Electricity Transmission Company manages, operates, and maintains high-voltage electricity grids. It acts purely as a utility infrastructure operator to transmit bulk power from power plants to regional distribution networks.
APX is Europe’s leading very-early-stage VC. Based in Berlin and backed by Axel Springer and Porsche, we support and partner with the most ambitious founding teams from Europe and beyond - often as their first investor.We invest up to EUR 500K in startups until a series A starting with a quick EUR 50K investment, and within a few months,depending on traction and speed, we can invest further. Each month we invest in new teams who become part of the APX community, counting hundreds of other founders. Since 2018, we have invested in 100+ startups across 20+ industries with founders from 20+ countries together with 100+ co-investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 191
- Round size: Seed $1M–$5M; Pre-Seed $55k–$1.5M; Series A $5M–$15M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $61M in 2021
Portfolio highlights
- VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
- Spike Technologies — Spike is an API for all fitness and health data from wearables & loT devices designed for digital health app developer.
- Track Titan — Titan Academy revolutionises how gamers improve through fully automated coaching.
Gerald has been an entrepreneur since 1999. At the age of 25 he founded PORTUM AG, the first European provider of b2b reverse online auctions and sourcing events with a trading volume of more than €10 billion which was sold to IBX / Cap Gemini in 2006. He then co-founded BuyVIP, an eCommerce shopping community and sold it to Amazon in 2010with more than 8 million members, 320 employees and a turnover of more than 140 million USD. In 2012, he founded Pippa&Jean, a social selling community that has helped more than 5,000 women to become self-employed and paid more than €10 million in commissions before being sold in 2018. In 2019, he founded youtiful, the world's first climate-neutral beauty involvement brand and cang.eco a subscription service for healthy and sustainable FMCG products which eventually had to shut down. Since then he has been focusing on Blockchain & Web 3.0 Investments and created with Shant Kevonian the Barcelona Blockchain Network, a tech incubator, venture studio and seed investor focused on web 3.0 from which they jointly founded EtherMail, the first web 3.0 email provider allowing wallet-to-wallet communication. Since 2006, Gerald has also been an active investor in start-up companies through Omnis Mundi and Firestartr, a network of entrepreneurs that he founded together with Alain Falys. He is a member of the Entrepreneurs Organisation (EO) and strongly believes in entrepreneurship as a way of life and, above all, as a means to make the world a better place.
Show more...Investment focus
- Industry: Retail, Content, Women's
- Stage:Seed, Pre-Seed
- Geography: Spain, Germany
Investor stats
- Total investments: 5
- Round size: Seed $549k–$768k; Pre-Seed $88k–$186k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- hello.app — Decentralized storage
- Modelmanagement.com — Model Management connects new faces and models with scouts, international modeling agencies and model photographers.
- Dana, by a thousand colibris SL — Dana is an app to improve the mental health and well-being of women transitioning through motherhood addressing the existing infra-diagnostic and lack of treatment. Dana is using audio-based psycho-educational content, mental and emotional self-assessment tools, combined with tele-consultation services and a mother’s community. Dana Therapeutics isa data-centrist AI solution based on behavioral sciences that offers advanced capabilities in prediction, detection and monitoring of patients suffering perinatal mental health disorders, while being able to measure the impact of the Dana intervention on patient improvement. Dana will complete the model with a mental health collaborative platform joining practitioners and data scientists to design custom and evolutive therapies.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 142
- Round size: Seed $2.7M–$14M; Series A $3.8M–$98M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 112
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$23M; Series B $3.3M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Equippo.com — Used construction equipment marketplace. Easy and safe. Only inspected machines. Worldwide delivery. Money Back Guaranteed. Buy Now, Pay Later!
- Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
- Sonic Emotion — Sonic Emotion Absolute 3DTM sound technology provides an innovative unique solution for an immersive natural 3D sound reproduction by implementing audio products with sound field control from only 2, 3, 4 or 6+ channels using a single compact device (and an optional subwoofer internal or external).
Medical Device Investor funding in Spain at a glance
Stats across 204 deals from 189 investors.
Access all 189 investors in Spain Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 189 investors investing in Spain Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!